trending Market Intelligence /marketintelligence/en/news-insights/trending/a7P3SMJc78Nox1S_ONbltQ2 content esgSubNav
In This List

Aurinia Pharmaceuticals appoints board member

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Aurinia Pharmaceuticals appoints board member

Aurinia Pharmaceuticals Inc. appointed Jeffry Randall to its board of directors and named him chairman of the audit committee.

Victoria, British Columbia-based Aurinia is a clinical stage biopharmaceutical company focused on the immunology market.